November 7, 2017 / 9:33 PM / 12 days ago

BRIEF-Halozyme reports Q3 EPS of $0.02

Nov 7 (Reuters) - Halozyme Therapeutics Inc

* Halozyme reports third quarter 2017 results

* Q3 earnings per share $0.02

* Q3 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S

* Q3 revenue $63.7 million versus i/b/e/s view $59 million

* Sees FY 2017 ‍net revenue of $265 million to $280 million​

* Qtrly ‍ cash, cash equivalents & marketable securities were $316.9 million at Sept. 30, 2017, versus $297.5 million at June 30, 2017​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below